PM577a Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

Prime Medicine, Inc.1

Indications

Wilsons Disease1
Wilson's Disease1
Liver Disease1
Wilson Disease1

Chicago, Illinois1 trial

A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)

Northwestern University Division of Gastroenterology and Hepatology

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.